Market Place
Sourcing Support
Boehringer, Zealand`s Obesity Drug Resembles Novo`s Wegovy
29 Apr 2026 //
BIOSPACE
Zealand Pharma Reveals Boehringer`s Dual Agonist Survodutide
28 Apr 2026 //
GLOBENEWSWIRE
Boehringer launches AI centre for pharma research in London
20 Apr 2026 //
REUTERS
Boehringer Ingelheim, Zai Lab Partner On Dll3-Targeting Combo
16 Apr 2026 //
GLOBENEWSWIRE
Boehringer Evaluates DLL3, PD-L1/VEGF-A Combo in SCLC
09 Apr 2026 //
GLOBENEWSWIRE
OpenProtein.AI Expands Boehringer Ingelheim AI Antibody Deal
31 Mar 2026 //
PR NEWSWIRE
CDR-Life Marks Initial Success In Boehringer Ingelheim
23 Mar 2026 //
PHARMIWEB
Boehringer Axes MASH Deal After OSE Asset Fails To Show Efficacy
02 Mar 2026 //
FIERCE BIOTECH
FDA Approves Hernexeos, the First Targeted Therapy for Adults
27 Feb 2026 //
GLOBENEWSWIRE
Boehringer Axes Gene Therapy After Seeing Cystic Fibrosis Data
17 Feb 2026 //
FIERCE BIOTECH
Boehringer Picks Brainomix e-Lung for Phase 3 Pulmonary Trial
20 Jan 2026 //
PHARMIWEB
Boehringer Progresses First-In-Class IL-11 Inhibitor in IPF
13 Jan 2026 //
GLOBENEWSWIRE
Boehringer Announces Clinical Collaboration with Jazz Pharma
12 Jan 2026 //
GLOBENEWSWIRE
Enara Bio Licenses Dark Antigen to Boehringer
08 Jan 2026 //
GLOBENEWSWIRE
Boehringer Spells Out A $448M Future For Rectify`s ABC Program
24 Dec 2025 //
FIERCE BIOTECH
Boehringer Cuts Ties To Nxera`s Phase 2-Ready Schizophrenia Drug
20 Dec 2025 //
FIERCE BIOTECH
Numab Hits Milestone with Boehringer Ingelheim
18 Dec 2025 //
GLOBENEWSWIRE
Galux, Boehringer Ingelheim Partner To Advance AI Protein Design
17 Dec 2025 //
BUSINESSWIRE
Boehringer Receives FDA Priority Voucher for Hernexeos
09 Nov 2025 //
PR NEWSWIRE
Boehringer Returns to Kyowa with €640 M Pact for Autoimmune Drug
30 Oct 2025 //
GLOBENEWSWIRE
Boehringer’s Zongertinib Shows 77% ORR in HER2+ NSCLC
17 Oct 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim Boosts Cancer ADC Portfolio With Aimedbio
15 Oct 2025 //
GLOBENEWSWIRE
Boehringer, Click Therapeutics Present Data On CT-155
13 Oct 2025 //
PR NEWSWIRE
Boehringer Ingelheim, Molcure Ink Multi-Year Ai-Driven Antibody
07 Oct 2025 //
INDPHARMAPOST
ERS Data: Nerandomilast Lowers Death Risk in IPF, PPF
30 Sep 2025 //
PHARMAWEB
Numab Achieves Milestone in Collaboration with Boehringer
25 Sep 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim Debuts Advanced Swine Vaccine in the US
03 Sep 2025 //
BUSINESSWIRE
Boehringer Ingelheim`s Hernexeos Receives China Approval
02 Sep 2025 //
GLOBENEWSWIRE
Boehringer, AnGes Ink Deal for HGF Gene Therapy Manufacturing
25 Aug 2025 //
INDPHARMAPOST
Boehringer, Palatin to Develop Novel Retinal Disease Treatment
18 Aug 2025 //
GLOBENEWSWIRE
FDA Approves Boehringer `s Lung Cancer Treatment
11 Aug 2025 //
REUTERS
Boehringer, Click’s CT-155 Meets Endpoint in Schizophrenia
07 Aug 2025 //
GLOBENEWSWIRE
Boehringer `crossing Fingers` Ahead of 2 Key FDA Approvals
26 Jul 2025 //
FIERCE BIOTECH
Boehringer Ingelheim starts Phase II study of BI 1815368
08 Jul 2025 //
GLOBENEWSWIRE
Oxford BioTherapeutics Advances Third Oncology Drug
03 Jul 2025 //
GLOBENEWSWIRE
Boehringer Launches Single-Dose Poultry Vaccine in India
18 Jun 2025 //
EXPRESSPHARMA
EFPIA Urges EU to Streamline Clinical Trials Under Biotech Act
12 Jun 2025 //
RAPS
OSE Immunotherapeutics & Boehringer Ingelheim to Present Clinical
23 May 2025 //
GLOBENEWSWIRE
Boehringer To Show SIRP? Blockade Data In ASCO 2025 Trials
22 May 2025 //
GLOBENEWSWIRE
Boehringer`s phase 3 lung data get muted response from analysts
20 May 2025 //
FIERCE BIOTECH
Boehringer slots synthetic lethal program into oncology pipeline
23 Apr 2025 //
FIERCE BIOTECH
Boehringer, Cue Bio partner for autoimmune & inflammatory diseases
14 Apr 2025 //
GLOBENEWSWIRE
Boehringer boosts ADC portfolio with NBE Therapeutics R&D center
03 Apr 2025 //
GLOBENEWSWIRE
Salipro Biotech, Boehringer Ingelheim Partner to Accelerate Pipeline
13 Mar 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim launches new trivalent poultry vaccine
24 Feb 2025 //
GLOBENEWSWIRE
Boehringer, Partner Begin Clinical Trial For Inhaled CF Gene Therapy
20 Feb 2025 //
GLOBENEWSWIRE
OXB’s Lentiviral Tech Supports Boehringer’s Ph 1/2 CF Gene Therapy Trial
20 Feb 2025 //
GLOBENEWSWIRE
Boehringer merges cancer vaccine and oncolytic virus team
25 Jan 2025 //
ENDPTS
Lonza`s Synaffix adds Boehringer to partners it with $1.3B ADC pact
10 Jan 2025 //
FIERCE BIOTECH
Boehringer Ingelheim Acquires Fourth Cancer Antibody License
09 Jan 2025 //
GLOBENEWSWIRE
Sutro, Boehringer Ingelheim Establish Commercial Cell-Free Tech
07 Jan 2025 //
GLOBENEWSWIRE
Boehringer Introduces Eurican L4 Vaccine For Leptospirosis
30 Nov 2024 //
PHARMABIZ
Boehringer`s Survodutide Cut Fibrosis, No MASH Worsening In 64.5%
07 Jun 2024 //
GLOBENEWSWIRE
Regeneron faces new biosimilar threats; an AI biotech lays off staff
22 May 2024 //
BIOPHARMADIVE
Boehringer enlists Cigna`s Quallent to expand Humira biosimilar reach
14 May 2024 //
FIERCE PHARMA
Boehringer Ingelheim Expands Access To Adalimumab Biosimilar Injection
13 May 2024 //
PR NEWSWIRE
Boehringer shares positive data from HORNBILL phase I/IIa study of BI 764524
06 May 2024 //
PHARMABIZ
FDA approves Boehringer Ingelheim’s Cyltezo for inflammatory ailments
02 May 2024 //
PHARMACEUTICAL TECHNOLOGY
FDA Approves BI`s Citrate-Free Cyltezo, Humira Biosimilar
01 May 2024 //
PR NEWSWIRE
Boehringer Ingelheim plots 25 new launches over the next decade
16 Apr 2024 //
FIERCE PHARMA
